Heffter Research Institute

From WikiMD's WELLNESSPEDIA

Heffter Research Institute is a non-profit organization that focuses on the research of psychedelic substances. The institute was founded in 1993 and is named after Arthur Heffter, a German scientist who was the first to isolate mescaline from the peyote cactus.

History[edit]

The Heffter Research Institute was established in 1993 by a group of scientists, including David E. Nichols, Dennis McKenna, and Mark Geyer. The institute was named in honor of Arthur Heffter, a German pharmacologist and chemist who was the first to isolate and identify mescaline, a psychedelic substance found in the peyote cactus.

Research[edit]

The institute's primary focus is on the research of psychedelic substances, particularly their potential therapeutic uses. The research conducted at the institute is multidisciplinary, encompassing fields such as psychiatry, neuroscience, and pharmacology. The institute has conducted studies on substances such as psilocybin, LSD, and MDMA, examining their potential use in treating conditions such as depression, anxiety, and post-traumatic stress disorder.

Funding[edit]

The Heffter Research Institute is a non-profit organization and relies on donations for funding. The institute has received funding from various sources, including private donors and foundations. The institute also collaborates with other research institutions and universities to conduct its research.

Impact[edit]

The research conducted at the Heffter Research Institute has contributed significantly to the field of psychedelic research. The institute's studies have helped to increase understanding of the potential therapeutic uses of psychedelic substances, and have contributed to a resurgence of interest in this field of research.

See also[edit]

References[edit]


External links[edit]

This article is a stub related to pharmacology. You can help WikiMD by expanding it!


Heffter Research Institute gallery[edit]

Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.

Retrieved from "https://wikimd.org/index.php?title=Heffter_Research_Institute&oldid=6418383"